Does RIBOCICLIB Cause Hepatitis fulminant? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Hepatitis fulminant have been filed in association with RIBOCICLIB (KISQALI). This represents 0.0% of all adverse event reports for RIBOCICLIB.
5
Reports of Hepatitis fulminant with RIBOCICLIB
0.0%
of all RIBOCICLIB reports
4
Deaths
1
Hospitalizations
How Dangerous Is Hepatitis fulminant From RIBOCICLIB?
Of the 5 reports, 4 (80.0%) resulted in death, 1 (20.0%) required hospitalization.
Is Hepatitis fulminant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RIBOCICLIB. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does RIBOCICLIB Cause?
Neutropenia (3,585)
Nausea (3,404)
Fatigue (3,327)
Malignant neoplasm progression (2,468)
Death (2,452)
Vomiting (1,953)
Diarrhoea (1,830)
White blood cell count decreased (1,683)
Pain (1,637)
Metastases to bone (1,538)
What Other Drugs Cause Hepatitis fulminant?
ACETAMINOPHEN (394)
NIVOLUMAB (60)
DEXAMETHASONE (59)
RITUXIMAB (51)
PEMBROLIZUMAB (50)
ATORVASTATIN (45)
IBUPROFEN (45)
PREDNISOLONE (45)
TRAMADOL (42)
AMIODARONE (40)
Which RIBOCICLIB Alternatives Have Lower Hepatitis fulminant Risk?
RIBOCICLIB vs RIBOFLAVIN
RIBOCICLIB vs RIBOFLAVIN 5'-PHOSPHATE
RIBOCICLIB vs RIBOFLAVIN 5^-PHOSPHATE
RIBOCICLIB vs RIFABUTIN
RIBOCICLIB vs RIFAMPICIN